April 5th 2025
High adherence rates, comparable clinical effectiveness, and cost savings have marked the early adoption of adalimumab biosimilars in the US, particularly in formulary-driven transitions, as shown in 2 retrospective studies presented at the Academy of Managed Care Pharmacy annual meeting (AMCP 2025).
Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Kno...
1.5 Credits / Immunology, Allergy
View More
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care...
May 20, 2025 | 1:00 PM and 8:00 PM ET
View More
Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-B...
1.5 Credits / Immunology
View More
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
1.5 Credits / Dermatology, Immunology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
1.0 Credit / Immunology, Neurology
View More
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
1.0 Credit / Gastroenterology, Immunology, Rare Diseases
View More
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
1.0 Credit / Immunology
View More
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
1.5 Credits / Allergy, Immunology
View More